Valuation: TOUE BIOPAR

Market Cap 1.24B 1.07B 1.01B 917M 1.73B 118B 1.75B 11.84B 4.62B 59.14B 4.65B 4.55B 197B P/E 2023
-2.95x
P/E 2024 -7.02x
Enterprise Value 980M 849M 796M 726M 1.37B 93.51B 1.39B 9.37B 3.66B 46.81B 3.68B 3.6B 156B EV / Sales 2023
-
EV / Sales 2024 -
Free-Float
-
Yield 2023 *
-
Yield 2024 -
1 year 21.3
Extreme 21.3
48.27
3 years 9.18
Extreme 9.18
48.31
5 years 9.18
Extreme 9.18
48.31
10 years 9.18
Extreme 9.18
48.31
Date Insider Type Main position Quantity % Market Cap.
28/10/25 OtherCompany 24,030,382 93.6139%
28/10/25 Tender

General Counsel

252,504 0.9837%
28/10/25 Issuer sale

Chairman

51,800 0.2018%

Financials

2023 2024
Net sales - -
Net income -42.12M -36.51M -34.23M -31.21M -58.72M -4.02B -59.66M -403M -157M -2.01B -158M -155M -6.71B -73.21M -63.46M -59.49M -54.24M -102M -6.99B -104M -700M -273M -3.5B -275M -269M -11.67B
Net Debt -203M -176M -165M -150M -282M -19.33B -287M -1.94B -757M -9.68B -760M -744M -32.28B -258M -224M -210M -191M -360M -24.63B -366M -2.47B -964M -12.33B -969M -948M -41.13B
Logo TOUE BIOPAR
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company. The Company is focused on developing transformative medicines that improve the lives of patients with life-altering immune and inflammatory diseases. The Company’s initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. TOUR006 is a long-acting anti-IL-6 antibody which has properties, including a high binding affinity to IL-6, long half-life, and low observed immunogenicity. It is also developing TOUR006 in thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD) as its first two indications, with additional diseases under consideration. It is focused on two strategic paths for TOUR006, the first of which it refers to as FcRn+. Its second strategic path is cardiovascular inflammation.
Employees
77
Sector
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. TRML Stock